Evidence map›Paper›PMID 30072909›Full record

ArticleFrontiers in physiology2018

A Bayesian Approach for the Use of Athlete Performance Data Within Anti-doping.

Silvia Montagna, James Hopker

Abstract read
In one paragraph

Article in Frontiers in physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Future opportunities for the Athlete Biological Passport.Frontiers in sports and active living · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Silvia MontagnaESOMAS Department, University of Torino, Torino, Italy.
James HopkerEndurance Research Group, School of Sport and Exercise Sciences, University of Kent, Medway, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Anti-doping Agency currently collates the results of all doping tests for athletes involved in elite sporting competition with the aim of improving the fight against doping. Existing anti-doping strategies involve either the direct detection of use of banned substances, or abnormal variation in metabolites or biological markers related to their use. As the aim of any doping regime is to enhance athlete competitive performance, it is interesting to consider whether performance data could be used within the fight against doping. In this regard, the identification of unexpected increases in athlete performance could be used as a trigger for their closer scrutiny via a targeted anti-doping testing programme. This study proposes a Bayesian framework for the development of an "athlete performance passport" and documents some initial findings and limitations of such an approach. The Bayesian model was retrospectively applied to the competitive results of 1,115 shot put athletes from 1975 to 2016 in order establish the interindividual variability of intraindividual performance in order to create individualized career performance trajectories for a large number of presumed clean athletes. Data from athletes convicted for doping violations (3.69% of the sample) was used to assess the predictive performance of the Bayesian framework with a probit model. Results demonstrate the ability to detect performance differences (~1 m) between doped and presumed clean athletes, and achieves good predictive performance of doping status (i.e., doped vs. non-doped) with a high area under the curve (AUC = 0.97). However, the model prediction of doping status was driven by the correct classification of presume non-doped athletes, misclassifying doped athletes as non-doped. This lack of sensitivity is likely due to the need to accommodate additional longitudinal covariates (e.g., aging and seasonality effects) potentially affecting performance into the framework. Further research is needed in order to increase the framework structure and improve its accuracy and sensitivity.

Indexed as

anti-dopingcompetition resultsdata analyticsmonitoringtarget testing

Identifiers

PMID30072909
PMCPMC6060570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.